Showing results (171-180 of 198) with videos related to
Sort By:
Pageof 20
Immunology|April 1, 1995
Human alpha beta T-cell receptor CD4-CD8 T-cell clones are predominantly Th0-likeP D Katsikis, S B Cohen, J G Murison, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1985
The distribution of the Qa-2 alloantigen on functional T lymphocytesP M Hogarth, A Basten, H Prichard-Briscoe, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1994
CD40 ligand (CD40L) expression and B cell function in agammaglobulinemia with normal or elevated levels of IgM (HIM). Comparison of X-linked, autosomal recessive, and non-X-linked forms of the disease, and obligate carriersR E Callard, S H Smith, J Herbert, et al.Human Genetics|October 1, 1987
Close linkage of random DNA fragments from Xq 21.3-22 to X-linked agammaglobulinaemia (XLA)S Malcolm, G de Saint Basile, B Arveiler, et al.European Journal of Immunology|December 1, 1994
Expression of Bruton's tyrosine kinase protein within the B cell lineageH C Genevier, S Hinshelwood, H B Gaspar, et al.Infection and Immunity|June 13, 2001
Dendritic cell activation and cytokine production induced by group B Neisseria meningitidis: interleukin-12 production depends on lipopolysaccharide expression in intact bacteriaG L Dixon, P J Newton, B M Chain, et al.Australian and New Zealand Journal of Medicine|February 1, 1985
Infantile complete heart block associated with maternal Ro(SS-A) ribonucleoprotein autoantibodies: report of two casesR J Epstein, P A Gatenby, S F Whittingham, et al.Australian and New Zealand Journal of Medicine|August 1, 1985
Central nervous system echovirus infection in Bruton's X-linked hypogammaglobulinemiaR L Prentice, A G Dalgleish, P A Gatenby, et al.Clinical Nuclear Medicine|March 1, 1996
Detection of malignant tumors using Tc-99m labeled Fab' fragments from a monoclonal antibody with specificity for D-dimer of cross-linked fibrinS Angelides, F T Lee, A Basten, et al.The Journal of Experimental Medicine|October 1, 1992
Immunoglobulin M and D antigen receptors are both capable of mediating B lymphocyte activation, deletion, or anergy after interaction with specific antigenR Brink, C C Goodnow, J Crosbie, et al.Pageof 20